Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (261-270 of 681) with videos related to

Pageof 69
Sort By:
Gynecologic Oncology Reports|August 5, 2025
Relationship between abnormal p53 expression and high-risk histology in endometrial cancers and living in proximity to hog concentrated animal feeding operations in North CarolinaJaye Boissiere, Samantha M Thomas, Yueqi Gu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2025
CH Mutations in 16,812 Advanced Cancer Patients-LetterEmmanuel S Antonarakis, Katherine L Nathanson, Kim A Reiss, et al.
International Journal of Molecular Sciences|January 11, 2025
Regulation of Age-Related Lipid Metabolism in Ovarian CancerJihua Feng, Clay Douglas Rouse, Lila Taylor, et al.
Gynecologic Oncology|March 16, 2007
Outcomes in surgical stage I uterine papillary serous carcinomaLaura J Havrilesky, Angeles Alvarez Secord, Victoria Bae-Jump, et al.
Gynecologic Oncology|May 3, 2005
Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer riskMonique A Spillman, Joellen M Schildkraut, Susan Halabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancerJaniel M Cragun, Laura J Havrilesky, Brian Calingaert, et al.
Current Problems in Cancer|March 1, 1996
Early ovarian cancer: a review of its genetic and biologic factors, detection, and treatmentM P Boente, T C Hamilton, A K Godwin, et al.
Gynecologic Oncology|September 22, 2009
Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group studyElizabeth L Jewell, Kathleen M Darcy, Alan Hutson, et al.
Gynecologic Oncology|January 13, 2009
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group studyJennifer M Rubatt, Kathleen M Darcy, Alan Hutson, et al.
Hybridoma|October 28, 1998
Coexpression of the HER-2 gene product, p185HER-2, and epidermal growth factor receptor, p170EGF-R, on epithelial ovarian cancers and normal tissuesR C Bast, L Pusztai, B J Kerns, et al.
Pageof 69

Showing results (261-270 of 681) with videos related to

Sort By:
Pageof 69
Gynecologic Oncology Reports|August 5, 2025
Relationship between abnormal p53 expression and high-risk histology in endometrial cancers and living in proximity to hog concentrated animal feeding operations in North CarolinaJaye Boissiere, Samantha M Thomas, Yueqi Gu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2025
CH Mutations in 16,812 Advanced Cancer Patients-LetterEmmanuel S Antonarakis, Katherine L Nathanson, Kim A Reiss, et al.
International Journal of Molecular Sciences|January 11, 2025
Regulation of Age-Related Lipid Metabolism in Ovarian CancerJihua Feng, Clay Douglas Rouse, Lila Taylor, et al.
Gynecologic Oncology|March 16, 2007
Outcomes in surgical stage I uterine papillary serous carcinomaLaura J Havrilesky, Angeles Alvarez Secord, Victoria Bae-Jump, et al.
Gynecologic Oncology|May 3, 2005
Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer riskMonique A Spillman, Joellen M Schildkraut, Susan Halabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancerJaniel M Cragun, Laura J Havrilesky, Brian Calingaert, et al.
Current Problems in Cancer|March 1, 1996
Early ovarian cancer: a review of its genetic and biologic factors, detection, and treatmentM P Boente, T C Hamilton, A K Godwin, et al.
Gynecologic Oncology|September 22, 2009
Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group studyElizabeth L Jewell, Kathleen M Darcy, Alan Hutson, et al.
Gynecologic Oncology|January 13, 2009
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group studyJennifer M Rubatt, Kathleen M Darcy, Alan Hutson, et al.
Hybridoma|October 28, 1998
Coexpression of the HER-2 gene product, p185HER-2, and epidermal growth factor receptor, p170EGF-R, on epithelial ovarian cancers and normal tissuesR C Bast, L Pusztai, B J Kerns, et al.
Pageof 69